Pneumococcal Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2023-05-24
EMA Authorised: Synflorix (Pneumococcal polysaccharide serotype 23F;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 5;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 7F;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 1;Pneumococcal polysaccharide serotype 14;Pneumococcal polysaccharide serotype 18C;Pneumococcal polysaccharide serotype 19F) — GlaxoSmithKline Biologicals S.A.
EMA has authorised Synflorix, a pneumococcal conjugate vaccine by GlaxoSmithKline Biologicals S.A., for immunization against multiple pneumo…